QUOTE AND NEWS
Motley Fool  4 hrs ago  Comment 
Medicaid enrollment has climbed by 80,000 in Texas despite the state opting out of Medicaid expansion.
Benzinga  Jun 27  Comment 
In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Centene (NYSE: CNC) with a Buy rating and $87.00 price target. In the report, Sterne Agee noted, “Centene has become the premier Medicaid pure-play and...
TheStreet.com  Jun 16  Comment 
NEW YORK (TheStreet) -- UBS increased its price target on Centene  to $70 and set a "neutral" rating based on substantial growth opportunities. The stock closed at $74.13 on Friday. Must Read: Warren Buffett's 25 Favorite Stocks STOCKS TO...
Benzinga  Jun 16  Comment 
In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Centene (NYSE: CNC). In the report, Morgan Stanley noted, “CNC signaled that it would update its current EPS guidance during its 2Q...
Benzinga  Jun 13  Comment 
Below are the top mid-cap health care plans stocks on the NYSE and the NASDAQ in terms of return on equity. The trailing-twelve-month return on equity at Centene (NYSE: CNC) is 25.10%. Centene's revenue for the same period is $11.80...
Market Intelligence Center  Jun 9  Comment 
MarketIntelligenceCenter.com’s patented algorithms have chosen the Aug. '14 $72.50 call for a couple of hedged-trading ideas on Centene (CNC). A traditional covered call on Centene yields 4.63% (24.87% annualized, for comparison purposes only)...
Benzinga  Jun 3  Comment 
In a research note released Monday, Citi analyst Carl McDonald downgraded Centene (NYSE: CNC) to Sell and set the price target at $65.00. The firm stated, “The Optimist Thinks This Is the Best of All Possible Worlds, And The Pessimist Knows...
TheStreet.com  Jun 3  Comment 
NEW YORK (TheStreet) -- Shares of Medicaid plan operators Centene  and WellCare  are declining after Citigroup wrote that Ascension Health is not buying a publicly traded Medicaid health plan, as was previously rumored. Ascension Health is a...
TheStreet.com  Jun 3  Comment 
NEW YORK (TheStreet) -- RATINGS CHANGES Allergan was downgraded at Credit Suisse to neutral from outperform. Twelve-month price target is $190. Risk/reward is balanced, following the latest bid from Valeant , Credit Suisse said. Big Lots was...
TheStreet.com  Jun 3  Comment 
NEW YORK (TheStreet) -- Centene  stock has been downgraded to "sell," Citigroup said Tuesday. The firm said the revision was because takeover rumors will likely fizzle out.  Must Read: Warren Buffett's 25 Favorite Stocks  STOCKS TO BUY:...





You may also be interested in articles related to Centene (CNC):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki